Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M Kuzel

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Clinical Lymphoma|November 15, 2001
DAB(389)IL-2 (denileukin diftitox, ONTAK): review of clinical trials to dateT M Kuzel
Oncology Nursing Forum|July 1, 1991
Cutaneous T-cell lymphomaK Gilyon, T M Kuzel
Hematology/Oncology Clinics of North America|October 1, 1995
Experimental therapies in the treatment of cutaneous T-cell lymphomaF M Foss, T M Kuzel
Current Treatment Options in Oncology|June 12, 2002
Cutaneous T-cell lymphoma/leukemiaR S Siegel, T M Kuzel
Cancer Treatment and Research|January 19, 1999
Novel treatment approaches for cutaneous T-cell lymphomaF M Foss, T M Kuzel
Current Opinion in Oncology|November 1, 1994
Antibodies in the treatment of human cancerT M Kuzel, S T Rosen
Cancer Treatment and Research|January 1, 1993
Radioimmunotherapy of lymphomaT M Kuzel, S T Rosen
Comprehensive Therapy|June 1, 1992
The current status of radiolabeled monoclonal antibodies for the diagnosis and treatment of human malignanciesT M Kuzel, R B Duda
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Mycosis fungoides and the Sézary syndrome: a review of pathogenesis, diagnosis, and therapyT M Kuzel, H H Roenigk, S T Rosen
Current Treatment Options in Oncology|June 12, 2002
Human T-cell lymphotropic-I-associated leukemia/lymphomaR S Siegel, R B Gartenhaus, T M Kuzel
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Clinical Lymphoma|November 15, 2001
DAB(389)IL-2 (denileukin diftitox, ONTAK): review of clinical trials to dateT M Kuzel
Oncology Nursing Forum|July 1, 1991
Cutaneous T-cell lymphomaK Gilyon, T M Kuzel
Hematology/Oncology Clinics of North America|October 1, 1995
Experimental therapies in the treatment of cutaneous T-cell lymphomaF M Foss, T M Kuzel
Current Treatment Options in Oncology|June 12, 2002
Cutaneous T-cell lymphoma/leukemiaR S Siegel, T M Kuzel
Cancer Treatment and Research|January 19, 1999
Novel treatment approaches for cutaneous T-cell lymphomaF M Foss, T M Kuzel
Current Opinion in Oncology|November 1, 1994
Antibodies in the treatment of human cancerT M Kuzel, S T Rosen
Cancer Treatment and Research|January 1, 1993
Radioimmunotherapy of lymphomaT M Kuzel, S T Rosen
Comprehensive Therapy|June 1, 1992
The current status of radiolabeled monoclonal antibodies for the diagnosis and treatment of human malignanciesT M Kuzel, R B Duda
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Mycosis fungoides and the Sézary syndrome: a review of pathogenesis, diagnosis, and therapyT M Kuzel, H H Roenigk, S T Rosen
Current Treatment Options in Oncology|June 12, 2002
Human T-cell lymphotropic-I-associated leukemia/lymphomaR S Siegel, R B Gartenhaus, T M Kuzel
Pageof 6